Koers ProMIS Neurosciences, Inc. Toronto S.E.
Aandelen
PMN
CA74346M4065
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 50,92 mln. 36,95 mln. 34,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -38 mln. -27,58 mln. -25,93 mln. | Nettowinst (verlies) 2025 * | -46 mln. -33,38 mln. -31,39 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,82
x | K/w-verhouding 2025 * |
-1,84
x | Werknemers | 7 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 13-05-21 |
Neil Cashman
FOU | Founder | 72 | 23-01-04 |
Eugene Williams
CHM | Chairman | 64 | 29-06-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 08-03-14 |
Neil Cashman
FOU | Founder | 72 | 23-01-04 |
Neil Warma
CEO | Chief Executive Officer | 61 | 13-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-0,44% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-7,45% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |